What are the major opportunities in the Giant-Cell Arteritis market? What are the strategies for the Giant-Cell Arteritis market?

For detailed insights on the major opportunities and strategies in the Giant-Cell Arteritis market, Read More

How does the Giant-Cell Arteritis market relate to the overall economy and other similar markets?

For detailed insights on Giant-Cell Arteritis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Giant-Cell Arteritis market growth? SWOT analysis of the Giant-Cell Arteritis market.

For detailed insights on the key dynamics influencing the Giant-Cell Arteritis market growth and SWOT analysis of the Giant-Cell Arteritis industry, Read More

Giant-Cell Arteritis Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Giant-Cell Arteritis Market Report 2026

Name: Giant-Cell Arteritis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapeutics (Prednisone, Methotrexate, Tocilizumab, Aspirin), By Mechanism Of Action (Corticosteroids, Immunosuppressive Agents, Anticoagulants, Other Mechanisms Of Action), By Route Of Administration (Oral, Intravenous, Subcutaneous, Other Routes Of Administration) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Giant-Cell Arteritis Market Overview

• Giant-Cell Arteritis market size has reached to $1.12 billion in 2025

• Expected to grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%

• Growth Driver: Embracing Personalized Medicine A Shift Towards Tailored Healthcare Solutions

• Market Trend: Major Developments In Giant-Cell Arteritis Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Giant-Cell Arteritis Market?

Giant-cell arteritis (GCA) is a type of vasculitis, or inflammation of blood vessels, predominantly affecting medium to large arteries. It commonly involves the temporal arteries, leading to headaches, scalp tenderness, and vision problems. GCA is characterized by inflammation of the vessel walls, potentially leading to serious complications such as blindness or stroke if untreated. Treatment typically involves high-dose corticosteroids to suppress inflammation and prevent complications.

The main giant-cell arteritis therapeutics are prednisone, methotrexate, tocilizumab, and aspirin. Prednisone is a corticosteroid medication that suppresses inflammation and the immune system. It has various mechanisms of action, such as corticosteroids, immunosuppressive agents, anticoagulants, and others, and it is administered through oral, intravenous, subcutaneous, and other routes.

Giant-Cell Arteritis Market Global Report 2026 Market Report bar graph

What Is The Giant-Cell Arteritis Market Size and Share 2026?

The giant-cell arteritis market size has grown steadily in recent years. It will grow from $1.12 billion in 2025 to $1.18 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to aging population growth, reliance on corticosteroid therapy, improved rheumatology care, expansion of hospital-based treatment, increased disease awareness.

What Is The Giant-Cell Arteritis Market Growth Forecast?

The giant-cell arteritis market size is expected to see steady growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to biologic drug approvals, growth in immunology research, improved diagnostic protocols, personalized vasculitis treatment, expansion of specialty clinics. Major trends in the forecast period include increased adoption of biologic therapies, rising focus on early and accurate diagnosis, expanded use of corticosteroid-sparing treatments, improved long-term disease monitoring, growing awareness of vision loss prevention.

Book your 30 minutes free consultation with our research experts

Global Giant-Cell Arteritis Market Segmentation

1) By Therapeutics: Prednisone, Methotrexate, Tocilizumab, Aspirin

2) By Mechanism Of Action: Corticosteroids, Immunosuppressive Agents, Anticoagulants, Other Mechanisms Of Action

3) By Route Of Administration: Oral, Intravenous, Subcutaneous, Other Routes Of Administration

Subsegments:

1) By Prednisone: Oral Prednisone, Intravenous (IV) Prednisone, Low-Dose Prednisone Therapy, High-Dose Prednisone Therapy

2) By Methotrexate: Oral Methotrexate, Subcutaneous Methotrexate, Methotrexate Monotherapy, Methotrexate Combination Therapy

3) By Tocilizumab: Intravenous Tocilizumab, Subcutaneous Tocilizumab, Tocilizumab Monotherapy, Tocilizumab In Combination With Corticosteroids

4) By Aspirin: Low-Dose Aspirin Therapy, Aspirin For Cardiovascular Risk Management, Aspirin In Combination Therapy, Enteric-Coated Aspirin

What Is The Driver Of The Giant-Cell Arteritis Market?

Growing emphasis on personalized medicine is expected to propel the growth of the giant-cell arteritis market going forward. Personalized medicine involves tailoring medical treatment to individual characteristics, such as genetics, lifestyle, and environment. Personalized medicine is increasing due to advancements in genomics, biotechnology, and data analytics, enabling targeted therapies that improve treatment efficacy and reduce adverse effects for individuals. Personalized medicine can aid in giant-cell arteritis (GCA) by allowing for targeted therapies based on individual patient factors such as genetic predispositions, immune profiles, and disease manifestations. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a U.S.-based non-profit organization, reported that personalized medicines accounted for over one-third of new drug approvals by the U.S. Food and Drug Administration (FDA) for the fourth consecutive year in 2023. During that year, the FDA approved 16 new personalized treatments tailored for rare diseases, a significant increase from six approvals in 2022. Additionally, the approvals in 2023 encompassed seven cancer medications and three treatments for various other diseases and conditions. Therefore, growing emphasis on personalized medicine is driving the growth of the giant-cell arteritis industry.

Key Players In The Global Giant-Cell Arteritis Market

Major companies operating in the giant-cell arteritis market are Roche, AbbVie, Novartis, Pfizer, Sanofi, GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen, Bristol-Myers Squibb, Johnson & Johnson, UCB S.A., Kiniksa Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co KGaA, CSL Limited, Dr Reddy’s Laboratories, Tianjin Tianyao Pharmaceutical Co Ltd, Gilead Sciences Inc, Sobi AB

Global Giant-Cell Arteritis Market Trends and Insights

Major companies operating in the giant-cell arteritis are developing new products, such as biosimilar to expand treatment options and address the unmet medical needs of patients. A biosimilar is a biologic drug that is highly similar to an already approved biological product, with no clinically meaningful differences in terms of safety, purity, and potency. For instance, in April 2024, Fresenius SE & Co. KGaA, a Germany-based healthcare company, launched Tocilizumab-aazg in the US for treating chronic autoimmune diseases. This biosimilar is approved for conditions such as rheumatoid arthritis (RA), systemic juvenile idiopathic arthritis (JIA), polyarticular juvenile idiopathic arthritis (PJIA), and giant cell arteritis. Its approval was based on data from a randomized, double-blind, single-dose, parallel phase 1 trial comparing its pharmacokinetics, safety, and immunogenicity to both US and EU reference tocilizumab in three patient groups.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Giant-Cell Arteritis Market?

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired Teva’s manufacturing facility in Goa, India, for an undisclosed amount. As a result of the acquisition, Marksans gains a 47,597-square-meter facility. This will enable the company to double its existing capacity in India from the current level of 8 billion units per year, allowing for the production of tablets, hard and soft gel capsules, ointments, liquids, and creams. Teva Pharmaceutical is an Israel-based manufacturer of prednisone tablets for giant-cell arteritis treatment.

Regional Outlook

North America was the largest region in the giant-cell arteritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Giant-Cell Arteritis Market?

The giant-cell arteritis market consists of revenues earned by entities by services such as monitoring and follow-up, supportive care, diagnostic testing, treatment administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The giant-cell arteritis market also includes sales of biologics, diagnostic tools, biopsy kits and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Giant-Cell Arteritis Market Report 2026?

The giant-cell arteritis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the giant-cell arteritis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Giant-Cell Arteritis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.18 billion
Revenue Forecast In 2035	$1.39 billion
Growth Rate	CAGR of 4.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapeutics, Mechanism Of Action, Route Of Administration
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Roche, AbbVie, Novartis, Pfizer, Sanofi, GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen, Bristol-Myers Squibb, Johnson & Johnson, UCB S.A., Kiniksa Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co KGaA, CSL Limited, Dr Reddy’s Laboratories, Tianjin Tianyao Pharmaceutical Co Ltd, Gilead Sciences Inc, Sobi AB
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Giant-Cell Arteritis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Giant-Cell Arteritis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Giant-Cell Arteritis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Giant-Cell Arteritis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Industry 4.0 And Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Increased Adoption Of Biologic Therapies

4.2.2 Rising Focus On Early And Accurate Diagnosis

4.2.3 Expanded Use Of Corticosteroid-Sparing Treatments

4.2.4 Improved Long-Term Disease Monitoring

4.2.5 Growing Awareness Of Vision Loss Prevention

5. Giant-Cell Arteritis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Rheumatology Clinics

5.3 Specialty Clinics

5.4 Diagnostic Centers

5.5 Academic Medical Centers

6. Giant-Cell Arteritis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Giant-Cell Arteritis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Giant-Cell Arteritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Giant-Cell Arteritis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Giant-Cell Arteritis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Giant-Cell Arteritis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Giant-Cell Arteritis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Giant-Cell Arteritis Market Segmentation

9.1. Global Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prednisone, Methotrexate, Tocilizumab, Aspirin

9.2. Global Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Corticosteroids, Immunosuppressive Agents, Anticoagulants, Other Mechanisms Of Action

9.3. Global Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Subcutaneous, Other Routes Of Administration

9.4. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Prednisone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Prednisone, Intravenous (IV) Prednisone, Low-Dose Prednisone Therapy, High-Dose Prednisone Therapy

9.5. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Methotrexate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Methotrexate, Subcutaneous Methotrexate, Methotrexate Monotherapy, Methotrexate Combination Therapy

9.6. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Tocilizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous Tocilizumab, Subcutaneous Tocilizumab, Tocilizumab Monotherapy, Tocilizumab In Combination With Corticosteroids

9.7. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Aspirin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Low-Dose Aspirin Therapy, Aspirin For Cardiovascular Risk Management, Aspirin In Combination Therapy, Enteric-Coated Aspirin

10. Giant-Cell Arteritis Market Regional And Country Analysis

10.1. Global Giant-Cell Arteritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Giant-Cell Arteritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Giant-Cell Arteritis Market

11.1. Asia-Pacific Giant-Cell Arteritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Giant-Cell Arteritis Market

12.1. China Giant-Cell Arteritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Giant-Cell Arteritis Market

13.1. India Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Giant-Cell Arteritis Market

14.1. Japan Giant-Cell Arteritis Market Overview

14.2. Japan Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Giant-Cell Arteritis Market

15.1. Australia Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Giant-Cell Arteritis Market

16.1. Indonesia Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Giant-Cell Arteritis Market

17.1. South Korea Giant-Cell Arteritis Market Overview

17.2. South Korea Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Giant-Cell Arteritis Market

18.1. Taiwan Giant-Cell Arteritis Market Overview

18.2. Taiwan Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Giant-Cell Arteritis Market

19.1. South East Asia Giant-Cell Arteritis Market Overview

19.2. South East Asia Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Giant-Cell Arteritis Market

20.1. Western Europe Giant-Cell Arteritis Market Overview

20.2. Western Europe Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Giant-Cell Arteritis Market

21.1. UK Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Giant-Cell Arteritis Market

22.1. Germany Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Giant-Cell Arteritis Market

23.1. France Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Giant-Cell Arteritis Market

24.1. Italy Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Giant-Cell Arteritis Market

25.1. Spain Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Giant-Cell Arteritis Market

26.1. Eastern Europe Giant-Cell Arteritis Market Overview

26.2. Eastern Europe Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Giant-Cell Arteritis Market

27.1. Russia Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Giant-Cell Arteritis Market

28.1. North America Giant-Cell Arteritis Market Overview

28.2. North America Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Giant-Cell Arteritis Market

29.1. USA Giant-Cell Arteritis Market Overview

29.2. USA Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Giant-Cell Arteritis Market

30.1. Canada Giant-Cell Arteritis Market Overview

30.2. Canada Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Giant-Cell Arteritis Market

31.1. South America Giant-Cell Arteritis Market Overview

31.2. South America Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Giant-Cell Arteritis Market

32.1. Brazil Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Giant-Cell Arteritis Market

33.1. Middle East Giant-Cell Arteritis Market Overview

33.2. Middle East Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Giant-Cell Arteritis Market

34.1. Africa Giant-Cell Arteritis Market Overview

34.2. Africa Giant-Cell Arteritis Market, Segmentation By Therapeutics, Segmentation By Mechanism Of Action, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Giant-Cell Arteritis Market Regulatory and Investment Landscape

36. Giant-Cell Arteritis Market Competitive Landscape And Company Profiles

36.1. Giant-Cell Arteritis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Giant-Cell Arteritis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Giant-Cell Arteritis Market Company Profiles

36.3.1. Roche Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Pfizer Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi Overview, Products and Services, Strategy and Financial Analysis

37. Giant-Cell Arteritis Market Other Major And Innovative Companies

GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen, Bristol-Myers Squibb, Johnson & Johnson, UCB S.A., Kiniksa Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co KGaA, CSL Limited, Dr Reddy’s Laboratories, Tianjin Tianyao Pharmaceutical Co Ltd, Gilead Sciences Inc, Sobi AB

38. Global Giant-Cell Arteritis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Giant-Cell Arteritis Market

40. Giant-Cell Arteritis Market High Potential Countries, Segments and Strategies

40.1 Giant-Cell Arteritis Market In 2030 - Countries Offering Most New Opportunities

40.2 Giant-Cell Arteritis Market In 2030 - Segments Offering Most New Opportunities

40.3 Giant-Cell Arteritis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Giant-Cell Arteritis Market, Overview Of Key Products - Product Examples

Table 2: Global Giant-Cell Arteritis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Giant-Cell Arteritis Market, Supply Chain Analysis

Table 4: Global Giant-Cell Arteritis Market, Major Raw Material Providers

Table 5: Global Giant-Cell Arteritis Market, Major Resource Providers

Table 6: Global Giant-Cell Arteritis Market, Major Manufacturers (Suppliers)

Table 7: Global Giant-Cell Arteritis Market, Major Distributors And Channel Partners

Table 8: Global Giant-Cell Arteritis Market, Key Technologies & Future Trends

Table 9: Global Giant-Cell Arteritis Market, Major Trends

Table 10: Global Giant-Cell Arteritis Market, Major End Users

Table 11: Global Giant-Cell Arteritis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Giant-Cell Arteritis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Giant-Cell Arteritis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Giant-Cell Arteritis Market - TAM, US$ Billion, 2025

Table 15: Global Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Prednisone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Methotrexate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Tocilizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Aspirin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Giant-Cell Arteritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Giant-Cell Arteritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Giant-Cell Arteritis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Giant-Cell Arteritis Market - Company Scoring Matrix

Table 98: Roche Financial Performance

Table 99: AbbVie Financial Performance

Table 100: Novartis Financial Performance

Table 101: Pfizer Financial Performance

Table 102: Sanofi Financial Performance

Table 103: Global Giant-Cell Arteritis Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Giant-Cell Arteritis Market, Competitive Dashboard

Table 105: Global Giant-Cell Arteritis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Giant-Cell Arteritis Market Size Gain ($ Billion), Segmentation By Therapeutics, 2025 – 2030

Table 107: Global, Giant-Cell Arteritis Market Size Gain ($ Billion), Segmentation By Mechanism Of Action, 2025 – 2030

Table 108: Global, Giant-Cell Arteritis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Giant-Cell Arteritis Market, Overview Of Key Products - Product Examples

Figure 2: Global Giant-Cell Arteritis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Giant-Cell Arteritis Market, Supply Chain Analysis

Figure 4: Global Giant-Cell Arteritis Market, Major Raw Material Providers

Figure 5: Global Giant-Cell Arteritis Market, Major Resource Providers

Figure 6: Global Giant-Cell Arteritis Market, Major Manufacturers (Suppliers)

Figure 7: Global Giant-Cell Arteritis Market, Major Distributors And Channel Partners

Figure 8: Global Giant-Cell Arteritis Market, Key Technologies & Future Trends

Figure 9: Global Giant-Cell Arteritis Market, Major Trends

Figure 10: Global Giant-Cell Arteritis Market, Major End Users

Figure 11: Global Giant-Cell Arteritis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Giant-Cell Arteritis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Giant-Cell Arteritis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Giant-Cell Arteritis Market - TAM, US$ Billion, 2025

Figure 15: Global Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Prednisone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Methotrexate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Tocilizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Giant-Cell Arteritis Market, Sub-Segmentation Of Aspirin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Giant-Cell Arteritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Giant-Cell Arteritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Giant-Cell Arteritis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Giant-Cell Arteritis Market - Company Scoring Matrix

Figure 98: Roche Financial Performance

Figure 99: AbbVie Financial Performance

Figure 100: Novartis Financial Performance

Figure 101: Pfizer Financial Performance

Figure 102: Sanofi Financial Performance

Figure 103: Global Giant-Cell Arteritis Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Giant-Cell Arteritis Market, Competitive Dashboard

Figure 105: Global Giant-Cell Arteritis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Giant-Cell Arteritis Market Size Gain ($ Billion), Segmentation By Therapeutics, 2025 – 2030

Figure 107: Global, Giant-Cell Arteritis Market Size Gain ($ Billion), Segmentation By Mechanism Of Action, 2025 – 2030

Figure 108: Global, Giant-Cell Arteritis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Small Cell Backhaul Market Report 2026 - Global Outlook – By Service (Network Services, Integration Services, Professional Services), By Transmission Medium (Wired, Wireless), By Backhaul Technology (Fiber, Millimeter Wa...

Rare Kidney Diseases Market Report 2026 - Global Outlook – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications...

Rare Inflammatory Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative...

Peripheral Artery Disease Market Report 2026 - Global Outlook – By Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynami...

Peripheral Arterial Disease Market Report 2026 - Global Outlook – By Treatment Type (Devices, Catheters, Drugs, Other Types), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End User (Ho...

Central Nervous System Lymphoma Treatment Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Corticosteroids, Immunotherapy), By Route Of Administration (Intraveno...

Mantle Cell Lymphoma Therapeutics Market Report 2026 - Global Outlook – By Type (Combination Therapy, Monotherapy), By Mechanism of Action (Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synt...

Frequently Asked Questions

How big is the Giant-Cell Arteritis Market?

The Giant-Cell Arteritis market was valued at $1.12 billion in 2025, increased to $1.18 billion in 2026, and is projected to reach $1.39 billion by 2030. request a sample here

What is the Giant-Cell Arteritis market growth?

The global Giant-Cell Arteritis market is expected to grow at a CAGR of 4.3% from 2026 to 2035 to reach $1.39 billion by 2035. request a sample here

Who are the key players in Giant-Cell Arteritis market?

Some Key Players in the Giant-Cell Arteritis market Include, Roche, AbbVie, Novartis, Pfizer, Sanofi, GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen, Bristol‑Myers Squibb, Johnson & Johnson, UCB S.A., Kiniksa Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co KGaA, CSL Limited, Dr Reddy’s Laboratories, Tianjin Tianyao Pharmaceutical Co Ltd, Gilead Sciences Inc, Sobi AB . request a sample here

What is the anticipated growth trend for the Giant-Cell Arteritis market?

Major trend in this market includes: Major Developments In Giant-Cell Arteritis Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the Giant-Cell Arteritis market?

North America was the largest region in the giant-cell arteritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the giant-cell arteritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Giant-Cell Arteritis Market Report 2026 market?

Major companies operating in the Giant-Cell Arteritis Market Report 2026 market are Major companies operating in the giant-cell arteritis market are Roche, AbbVie, Novartis, Pfizer, Sanofi, GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen, Bristol‑Myers Squibb, Johnson & Johnson, UCB S.A., Kiniksa Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co KGaA, CSL Limited, Dr Reddy’s Laboratories, Tianjin Tianyao Pharmaceutical Co Ltd, Gilead Sciences Inc, Sobi AB request a sample here.

Which region has the most growth potential in the Giant-Cell Arteritis Market Report 2026 market?